uracil has been researched along with Peritoneal Carcinomatosis in 26 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 9.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "The high mortality of epithelial ovarian cancer (EOC) is primarily due to vast intraperitoneal dissemination." | 5.51 | 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer. ( Gao, H; Guo, X; Li, X; Liu, N; Peng, J; Yang, X, 2019) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 5.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited." | 2.73 | Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. ( Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB, 2007) |
| "Uracil-tegafur (UFT) has been reported to have a broad anti-tumor activity in a variety of malignancies including colorectal cancer and breast cancer." | 2.70 | Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer. ( Ikeda, M; Kuriyama, H; Okada, S; Okusaka, T; Ueno, H, 2002) |
| "The high mortality of epithelial ovarian cancer (EOC) is primarily due to vast intraperitoneal dissemination." | 1.51 | 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer. ( Gao, H; Guo, X; Li, X; Liu, N; Peng, J; Yang, X, 2019) |
| "However, the role of MCTs in gastric cancer (GC) is not fully understood." | 1.43 | MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. ( Ahn, SM; Chang, WJ; Cho, JH; Jung, KS; Kang, WK; Kim, HS; Kim, KM; Kim, ST; Kim, SY; Lee, I; Lee, J; Lee, JY; Lee, S; Lim, HY; Lim, SH; Park, JO; Park, SH; Park, YS; Song, HN; Yoo, KH, 2016) |
| "Peritoneal metastasis of breast cancer was suspected, and an operation was performed for a definitive diagnosis." | 1.42 | [A Case of Peritoneal Metastasis of Breast Cancer Diagnosed by Laparoscopic-Assisted Right Hemicolectomy]. ( Egawa, C; Goto, T; Hashimoto, T; Ishida, T; Kagawa, Y; Kato, T; Katsura, Y; Kimura, K; Kusama, H; Matsushita, K; Morimoto, Y; Motoyama, Y; Murakami, K; Nagano, T; Naito, A; Nakatsuka, S; Nitta, K; Ohmura, Y; Ohneda, Y; Okishiro, M; Sakisaka, H; Sato, Y; Takatsuka, Y; Takeda, Y; Takeno, A; Tamura, S; Taniguchi, H, 2015) |
| " We conducted an analysis to evaluate the efficacy and feasibility of modified pharmacokinetic modulating chemotherapy, for gastric cancer patients with peritoneal dissemination." | 1.33 | [Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination]. ( Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T, 2005) |
| "Treatment of advanced gastric cancers with peritonitis carcinomatosa is very difficult, because none of the various therapies (operation, chemotherapy, hyperthermia etc." | 1.32 | [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites]. ( Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M, 2004) |
| "Spontaneous regression of hepatocellular carcinoma (HCC) is a rare phenomenon." | 1.31 | Complete disappearance of recurrent hepatocellular carcinoma with peritoneal dissemination and splenic metastasis: a unique clinical course after surgery. ( Amano, J; Hanazaki, K; Koide, N; Matsunaga, Y; Shiohara, E; Terasaki, T, 2000) |
| "We encountered a case of unresectable colon cancer that disappeared following pharmacokinetic modulating chemotherapy (PMC)." | 1.31 | [A case report of unresectable colon cancer that disappeared following pharmacokinetic modulation chemotherapy (PMC)]. ( Asahara, T; Nakahara, H; Nakahara, M; Okajima, M; Yano, M, 2000) |
| "We reported a case of gastric cancer with peritoneal dissemination, which was successfully treated by neoadjuvant chemotherapy and partial gastrectomy." | 1.29 | [Case report of long-term survivor of advanced gastric cancer associated with peritoneal dissemination successfully treated with cancer chemotherapy]. ( Ikeda, K; Shibata, N; Tamai, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 14 (53.85) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, J | 1 |
| Yang, X | 1 |
| Li, X | 1 |
| Gao, H | 1 |
| Liu, N | 1 |
| Guo, X | 1 |
| Sato, Y | 1 |
| Okishiro, M | 1 |
| Ohneda, Y | 1 |
| Motoyama, Y | 1 |
| Ishida, T | 1 |
| Morimoto, Y | 1 |
| Kusama, H | 1 |
| Matsushita, K | 1 |
| Hashimoto, T | 1 |
| Kimura, K | 1 |
| Naito, A | 1 |
| Murakami, K | 1 |
| Katsura, Y | 1 |
| Nitta, K | 1 |
| Ohmura, Y | 1 |
| Kagawa, Y | 1 |
| Takeno, A | 1 |
| Sakisaka, H | 1 |
| Taniguchi, H | 1 |
| Egawa, C | 1 |
| Takeda, Y | 1 |
| Kato, T | 1 |
| Tamura, S | 1 |
| Takatsuka, Y | 1 |
| Goto, T | 1 |
| Nagano, T | 1 |
| Nakatsuka, S | 1 |
| Lee, JY | 1 |
| Lee, I | 1 |
| Chang, WJ | 1 |
| Ahn, SM | 1 |
| Lim, SH | 1 |
| Kim, HS | 1 |
| Yoo, KH | 1 |
| Jung, KS | 1 |
| Song, HN | 1 |
| Cho, JH | 1 |
| Kim, SY | 1 |
| Kim, KM | 1 |
| Lee, S | 1 |
| Kim, ST | 1 |
| Park, SH | 1 |
| Lee, J | 1 |
| Park, JO | 1 |
| Park, YS | 1 |
| Lim, HY | 1 |
| Kang, WK | 1 |
| Suzuki, E | 1 |
| Furuse, J | 1 |
| Ikeda, M | 2 |
| Ishii, H | 1 |
| Okusaka, T | 2 |
| Nakachi, K | 1 |
| Mitsunaga, S | 1 |
| Ueno, H | 2 |
| Morizane, C | 1 |
| Usuki, H | 1 |
| Ishimura, K | 1 |
| Yachida, S | 1 |
| Hagiike, M | 1 |
| Okano, K | 1 |
| Izuishi, K | 1 |
| Karasawa, Y | 1 |
| Goda, F | 1 |
| Maeta, H | 1 |
| Terashima, M | 1 |
| Fujiwara, H | 1 |
| Takagane, A | 1 |
| Abe, K | 1 |
| Irinoda, T | 1 |
| Nakaya, T | 1 |
| Yonezawa, H | 1 |
| Oyama, K | 1 |
| Saito, K | 1 |
| Kanzaki, N | 1 |
| Ohtani, S | 1 |
| Nemoto, T | 1 |
| Hoshino, Y | 1 |
| Kogure, M | 1 |
| Gotoh, M | 1 |
| Nakayama, H | 1 |
| Aoki, N | 1 |
| Hayashi, S | 1 |
| Wakabayashi, K | 1 |
| Karube, H | 1 |
| Ogame, H | 1 |
| Aoki, H | 1 |
| Sakamoto, N | 1 |
| Masuda, H | 1 |
| Hemmi, A | 1 |
| Nakamura, T | 1 |
| Shimada, K | 1 |
| Okubo, Y | 1 |
| Tanaka, S | 1 |
| Tanabe, S | 1 |
| Yoshida, M | 1 |
| Doi, K | 1 |
| Uchinami, M | 1 |
| Horiuchi, T | 1 |
| Tanaka, K | 1 |
| Ishikawa, T | 2 |
| Mizuno, K | 1 |
| Togashi, T | 1 |
| Watanabe, K | 1 |
| Seki, K | 1 |
| Ohta, H | 1 |
| Yoshida, T | 1 |
| Kamimura, T | 1 |
| Okabayashi, K | 1 |
| Hasegawa, H | 1 |
| Kawano, Y | 1 |
| Kawano, S | 1 |
| Nishibori, H | 1 |
| Ishii, Y | 1 |
| Yamauchi, T | 1 |
| Kawano, T | 1 |
| Kitajima, M | 1 |
| Asai, K | 1 |
| Fujita, T | 1 |
| Nakamura, Y | 1 |
| Tokuda, E | 1 |
| Hiyoshi, M | 1 |
| Aoki, F | 1 |
| Sugizaki, K | 1 |
| Masaki, Y | 1 |
| Shibaki, T | 1 |
| Morimoto, N | 1 |
| Idelevich, E | 1 |
| Karminsky, N | 1 |
| Dinerman, M | 1 |
| Katsenelson, RL | 1 |
| Zvi, NB | 1 |
| Baruch, NB | 1 |
| Biran, H | 1 |
| Man, S | 1 |
| Shani, A | 1 |
| Shibata, N | 1 |
| Tamai, M | 1 |
| Ikeda, K | 2 |
| Yoshiyuki, T | 1 |
| Onda, M | 1 |
| Tokunaga, A | 1 |
| Teramoto, T | 1 |
| Oguri, T | 1 |
| Fujita, I | 1 |
| Okuda, T | 1 |
| Mizutani, T | 1 |
| Kiyama, T | 1 |
| Shimizu, Y | 1 |
| Maehara, Y | 1 |
| Okuyama, T | 1 |
| Kakeji, Y | 1 |
| Baba, H | 1 |
| Furusawa, M | 1 |
| Sugimachi, K | 1 |
| Otani, S | 1 |
| Maeta, M | 1 |
| Oka, A | 1 |
| Hirooka, Y | 1 |
| Tsujitani, S | 1 |
| Ikeguchi, M | 1 |
| Hamazoe, R | 1 |
| Kaibara, N | 1 |
| Ohtani, M | 1 |
| Takayama, S | 1 |
| Ogata, N | 1 |
| Sekine, C | 1 |
| Nimura, H | 1 |
| Tsutsumi, J | 1 |
| Kashimura, H | 1 |
| Sano, Y | 1 |
| Inoue, Y | 1 |
| Aoki, T | 1 |
| Ito, H | 1 |
| Imada, T | 1 |
| Kondo, J | 1 |
| Amano, T | 1 |
| Maehara, T | 1 |
| Rino, Y | 1 |
| Takahashi, M | 1 |
| Shiozawa, M | 1 |
| Hatori, S | 1 |
| Suzuki, Y | 1 |
| Terasaki, T | 1 |
| Hanazaki, K | 1 |
| Shiohara, E | 1 |
| Matsunaga, Y | 1 |
| Koide, N | 1 |
| Amano, J | 1 |
| Nakahara, H | 1 |
| Okajima, M | 1 |
| Nakahara, M | 1 |
| Yano, M | 1 |
| Asahara, T | 1 |
| Ogawa, Y | 1 |
| Ogisawa, K | 1 |
| Nagatsuka, I | 1 |
| Matsumura, Y | 1 |
| Takashima, T | 1 |
| Yashiro, M | 1 |
| Onoda, N | 1 |
| Nakata, B | 1 |
| Kato, Y | 1 |
| Hirakawa, K | 1 |
| Akamo, Y | 1 |
| Takeyama, H | 1 |
| Hasegawa, M | 1 |
| Teranishi, F | 1 |
| Manabe, T | 1 |
| Okada, S | 1 |
| Kuriyama, H | 1 |
| Hayashi, T | 1 |
| Nasu, Y | 1 |
| Aramaki, K | 1 |
| Johsen, T | 1 |
| Matsuura, H | 1 |
| Schmähl, D | 1 |
6 trials available for uracil and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carci | 2011 |
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Ch | 2003 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplat | 2007 |
[Treatment for peritoneal dissemination of gastric cancer by intraperitoneal administration of CDDP through Infuse-a-Port].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 1994 |
Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modali | 1994 |
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; | 2002 |
20 other studies available for uracil and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Adhesion; Cell Line, Tumor; Female; Focal Adhesion Kina | 2019 |
[A Case of Peritoneal Metastasis of Breast Cancer Diagnosed by Laparoscopic-Assisted Right Hemicolectomy].
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemothe | 2015 |
MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; F | 2016 |
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehyd | 2003 |
[A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryo | 2004 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administrati | 2004 |
[Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemot | 2005 |
[A case of colorectal cancer effectively treated with UFT/LV].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Mo | 2005 |
[A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Col | 2005 |
[Advanced rectal cancer in an older patient, in whom metastatic liver lesions were effectively controlled with oral UFT+LV and venous CPT-11 administration--case report].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2006 |
[Case report of long-term survivor of advanced gastric cancer associated with peritoneal dissemination successfully treated with cancer chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouraci | 1995 |
Long-term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis: report of a case.
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fatal Outcome; | 1995 |
[Usefulness of contrast-enhanced CT of the peritoneum to evaluate efficacy of neoadjuvant chemotherapy for peritoneal dissemination in an advanced gastric cancer case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combin | 1996 |
A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Combined Modality Therapy | 1998 |
Complete disappearance of recurrent hepatocellular carcinoma with peritoneal dissemination and splenic metastasis: a unique clinical course after surgery.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Thera | 2000 |
[A case report of unresectable colon cancer that disappeared following pharmacokinetic modulation chemotherapy (PMC)].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug | 2000 |
[Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplas | 2000 |
[Efficacy of intraperitoneal chemotherapy for peritoneal recurrence of gastric carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2001 |
[A case of peritoneal malignant mesothelioma with disappearance of ascites result of intraperitoneal instillation of mitomycin C and oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cryptorch | 1989 |
[Examination of 1,3-dimethyl-4-amino-5-nitroso-uracile for carcinogenic effect in rats (author's transl)].
Topics: Animals; Chemical Phenomena; Chemistry; Fibrosarcoma; Injections, Intraperitoneal; Leukemia; Lymphom | 1973 |